A comparative, single blind, parallel group, non-crossover, multi-centric trial of Imidafenacin Tablets 0.1 mg, with Uritos Tablets, in-patients suffering from Overactive Bladder.

Trial Profile

A comparative, single blind, parallel group, non-crossover, multi-centric trial of Imidafenacin Tablets 0.1 mg, with Uritos Tablets, in-patients suffering from Overactive Bladder.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Imidafenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Sep 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
    • 04 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
    • 12 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top